LATEST
GTCR agreed to acquire CCC Intelligent SolutionsnewEQT agreed to acquire StockbridgenewProofpoint agreed to acquire VaronisnewMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire RocscienceSRS Acquiom / PantaraiSpaceX agreed to acquire nationwide 800 MHz spectrum portfolioAEA Investors acquired RensaWittington Investments agreed to acquire BootsEurazeo / MIYA Water: majority stake
Open App
ClosedPublished 17 Jul 2026

Jasper Therapeutics, Inc. /
Kira Pharmaceuticals

Jasper Therapeutics completes Kira Pharmaceuticals merger

Buy side: Jasper Therapeutics, Inc.
Buy sideJasper Therapeutics, Inc.
Target: Kira Pharmaceuticals
TargetKira Pharmaceuticals
Jasper Therapeutics, Inc. · 17 Jul 2026Source
See the source
Follow Jasper Therapeutics, Inc. Follow Kira Pharmaceuticals
Buy side: Jasper Therapeutics, Inc.
Buy sideJasper Therapeutics, Inc.
Target: Kira Pharmaceuticals
TargetKira Pharmaceuticals
01 / BuyerJasper Therapeutics, Inc.
02 / TargetKira Pharmaceuticals
Source for the buyer and target: Jasper Therapeutics, Inc.

For the buyer and target.

“On July 16, 2026, Jasper Therapeutics, Inc., a Delaware corporation (the “Company” or “Jasper”), acquired Kira Pharmaceuticals (“Kira”), a Cayman Islands exempted company, in accordance with the terms of the Agreement and Plan of Merger, dated July 16, 2026 (the “Merger Agreement”), by and among the Company, Kira and Kira Holdco Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”).”

Published 17 Jul 2026

Open the source
01

What happened

Jasper Therapeutics, Inc. acquired Kira Pharmaceuticals on July 16, 2026, through a merger in which Kira merged into Kira Holdco Inc., a wholly owned subsidiary of Jasper Therapeutics, Inc. [01]

As merger consideration, Jasper Therapeutics, Inc. issued Kira shareholders 5,195,009 shares of voting common stock and 4,644,977 shares of non-voting convertible preferred stock. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Jasper Therapeutics, Inc.

Jasper Therapeutics completes Kira Pharmaceuticals merger

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    “Jasper Therapeutics completes Kira Pharmaceuticals merger Jasper Therapeutics, Inc. acquired Kira Pharmaceuticals on July 16, 2026, through a merger in which Kira merged into Kira Holdco Inc., a wholly owned subsidiar…”

    Open the source

  2. Published by Jasper Therapeutics, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.

04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 2 firms · 0 peopleHover a name to see how it connects
This dealJasper Therapeutics, Inc. / Kira PharmaceuticalsClosed · Published 17 Jul 2026
BuyerJasper Therapeutics, Inc.TargetKira Pharmaceuticals
This dealJasper Therapeutics, Inc. / Kira Pharmaceuticals

Closed · Jasper Therapeutics, Inc. acquired Kira Pharmaceuticals (Closed, published 17 Jul 2026).

Closed 16 Jul 2026
Timeline
  1. Closed
  2. Published by Jasper Therapeutics, Inc.
Hover or tap a name to see how it connects, and when
Deal Web as a list